In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent

A novel nanoparticle-based dual-modality positron emission tomograph/magnetic resonance imaging (PET/MRI) contrast agent was developed. The probe consisted of a superparamagnetic iron oxide (SPIO) core coated with PEGylated phospholipids. The chelator 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioconjugate chemistry 2010-04, Vol.21 (4), p.715-722
Hauptverfasser: Glaus, Charles, Rossin, Raffaella, Welch, Michael J, Bao, Gang
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 722
container_issue 4
container_start_page 715
container_title Bioconjugate chemistry
container_volume 21
creator Glaus, Charles
Rossin, Raffaella
Welch, Michael J
Bao, Gang
description A novel nanoparticle-based dual-modality positron emission tomograph/magnetic resonance imaging (PET/MRI) contrast agent was developed. The probe consisted of a superparamagnetic iron oxide (SPIO) core coated with PEGylated phospholipids. The chelator 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid (DOTA) was conjugated to PEG termini to allow labeling with positron-emitting 64Cu. Radiolabeling with 64Cu at high yield and high purity was readily achieved. The 64Cu-SPIO probes produced strong MR and PET signals and were stable in mouse serum for 24 h at 37 °C. Biodistribution and in vivo PET/CT imaging studies of the probes showed a circulation half-life of 143 min and high initial blood retention with moderate liver uptake, making them an attractive contrast agent for disease studies.
doi_str_mv 10.1021/bc900511j
format Article
fullrecord <record><control><sourceid>acs_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2865436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a500763655</sourcerecordid><originalsourceid>FETCH-LOGICAL-a205t-e915bdb1d00ceb19885c82105f56cdef208df505edf69d1cc13e44a4694401253</originalsourceid><addsrcrecordid>eNpVkN1LwzAUxYMobn48-B_kxce6e9Okpi_CmFMHm4qor-E2SWtG145-DPbfW5kIwoF74MDvHg5jVwg3CAInmU0BFOL6iI1RCYikRnE8eJBxhBrEiJ217RoAUtTilI0ExCrGWxgzWlT8M-xqPt9R2VMX6orXOU_krI-WlPnSO76iovJdsPyZqnpLzWBL33IaxO97KqNV7agM3Z6_zt8nqze-2FARqoJPC191F-wkp7L1l7_3nH08zN9nT9Hy5XExmy4jEqC6yKeoMpehA7A-w1RrZbVAULlKrPO5AO1yBcq7PEkdWouxl5JkkkoJKFR8zu4O3G2fbbyzw-uGSrNtwoaavakpmP9JFb5MUe-M0ImScTIArg8Asq1Z131TDXUNgvnZ2PxtHH8DJItsvQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent</title><source>ACS Publications</source><creator>Glaus, Charles ; Rossin, Raffaella ; Welch, Michael J ; Bao, Gang</creator><creatorcontrib>Glaus, Charles ; Rossin, Raffaella ; Welch, Michael J ; Bao, Gang</creatorcontrib><description>A novel nanoparticle-based dual-modality positron emission tomograph/magnetic resonance imaging (PET/MRI) contrast agent was developed. The probe consisted of a superparamagnetic iron oxide (SPIO) core coated with PEGylated phospholipids. The chelator 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid (DOTA) was conjugated to PEG termini to allow labeling with positron-emitting 64Cu. Radiolabeling with 64Cu at high yield and high purity was readily achieved. The 64Cu-SPIO probes produced strong MR and PET signals and were stable in mouse serum for 24 h at 37 °C. Biodistribution and in vivo PET/CT imaging studies of the probes showed a circulation half-life of 143 min and high initial blood retention with moderate liver uptake, making them an attractive contrast agent for disease studies.</description><identifier>ISSN: 1043-1802</identifier><identifier>EISSN: 1520-4812</identifier><identifier>DOI: 10.1021/bc900511j</identifier><identifier>PMID: 20353170</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Bioconjugate chemistry, 2010-04, Vol.21 (4), p.715-722</ispartof><rights>Copyright © 2010 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bc900511j$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bc900511j$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,780,784,885,27076,27924,27925,56738,56788</link.rule.ids></links><search><creatorcontrib>Glaus, Charles</creatorcontrib><creatorcontrib>Rossin, Raffaella</creatorcontrib><creatorcontrib>Welch, Michael J</creatorcontrib><creatorcontrib>Bao, Gang</creatorcontrib><title>In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent</title><title>Bioconjugate chemistry</title><addtitle>Bioconjugate Chem</addtitle><description>A novel nanoparticle-based dual-modality positron emission tomograph/magnetic resonance imaging (PET/MRI) contrast agent was developed. The probe consisted of a superparamagnetic iron oxide (SPIO) core coated with PEGylated phospholipids. The chelator 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid (DOTA) was conjugated to PEG termini to allow labeling with positron-emitting 64Cu. Radiolabeling with 64Cu at high yield and high purity was readily achieved. The 64Cu-SPIO probes produced strong MR and PET signals and were stable in mouse serum for 24 h at 37 °C. Biodistribution and in vivo PET/CT imaging studies of the probes showed a circulation half-life of 143 min and high initial blood retention with moderate liver uptake, making them an attractive contrast agent for disease studies.</description><issn>1043-1802</issn><issn>1520-4812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpVkN1LwzAUxYMobn48-B_kxce6e9Okpi_CmFMHm4qor-E2SWtG145-DPbfW5kIwoF74MDvHg5jVwg3CAInmU0BFOL6iI1RCYikRnE8eJBxhBrEiJ217RoAUtTilI0ExCrGWxgzWlT8M-xqPt9R2VMX6orXOU_krI-WlPnSO76iovJdsPyZqnpLzWBL33IaxO97KqNV7agM3Z6_zt8nqze-2FARqoJPC191F-wkp7L1l7_3nH08zN9nT9Hy5XExmy4jEqC6yKeoMpehA7A-w1RrZbVAULlKrPO5AO1yBcq7PEkdWouxl5JkkkoJKFR8zu4O3G2fbbyzw-uGSrNtwoaavakpmP9JFb5MUe-M0ImScTIArg8Asq1Z131TDXUNgvnZ2PxtHH8DJItsvQ</recordid><startdate>20100421</startdate><enddate>20100421</enddate><creator>Glaus, Charles</creator><creator>Rossin, Raffaella</creator><creator>Welch, Michael J</creator><creator>Bao, Gang</creator><general>American Chemical Society</general><scope>5PM</scope></search><sort><creationdate>20100421</creationdate><title>In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent</title><author>Glaus, Charles ; Rossin, Raffaella ; Welch, Michael J ; Bao, Gang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a205t-e915bdb1d00ceb19885c82105f56cdef208df505edf69d1cc13e44a4694401253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glaus, Charles</creatorcontrib><creatorcontrib>Rossin, Raffaella</creatorcontrib><creatorcontrib>Welch, Michael J</creatorcontrib><creatorcontrib>Bao, Gang</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioconjugate chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glaus, Charles</au><au>Rossin, Raffaella</au><au>Welch, Michael J</au><au>Bao, Gang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent</atitle><jtitle>Bioconjugate chemistry</jtitle><addtitle>Bioconjugate Chem</addtitle><date>2010-04-21</date><risdate>2010</risdate><volume>21</volume><issue>4</issue><spage>715</spage><epage>722</epage><pages>715-722</pages><issn>1043-1802</issn><eissn>1520-4812</eissn><abstract>A novel nanoparticle-based dual-modality positron emission tomograph/magnetic resonance imaging (PET/MRI) contrast agent was developed. The probe consisted of a superparamagnetic iron oxide (SPIO) core coated with PEGylated phospholipids. The chelator 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid (DOTA) was conjugated to PEG termini to allow labeling with positron-emitting 64Cu. Radiolabeling with 64Cu at high yield and high purity was readily achieved. The 64Cu-SPIO probes produced strong MR and PET signals and were stable in mouse serum for 24 h at 37 °C. Biodistribution and in vivo PET/CT imaging studies of the probes showed a circulation half-life of 143 min and high initial blood retention with moderate liver uptake, making them an attractive contrast agent for disease studies.</abstract><pub>American Chemical Society</pub><pmid>20353170</pmid><doi>10.1021/bc900511j</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1043-1802
ispartof Bioconjugate chemistry, 2010-04, Vol.21 (4), p.715-722
issn 1043-1802
1520-4812
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2865436
source ACS Publications
title In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A48%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vivo%20Evaluation%20of%2064Cu-Labeled%20Magnetic%20Nanoparticles%20as%20a%20Dual-Modality%20PET/MR%20Imaging%20Agent&rft.jtitle=Bioconjugate%20chemistry&rft.au=Glaus,%20Charles&rft.date=2010-04-21&rft.volume=21&rft.issue=4&rft.spage=715&rft.epage=722&rft.pages=715-722&rft.issn=1043-1802&rft.eissn=1520-4812&rft_id=info:doi/10.1021/bc900511j&rft_dat=%3Cacs_pubme%3Ea500763655%3C/acs_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/20353170&rfr_iscdi=true